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Tingible Body Macrophages in Regulation of Germinal
Center Reactions
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aDepartment ofAnatomy, Division of Immunobiology,; bDepartment of Microbiology and Immunology, Virginia Commonwealth
University, Medical College of Virginia, Richmond, Virginia
(Received 2 November 1996; in final form 3 June 1997)
Tingible body macrophages (TBM), long thought simply as scavengers of apoptotic
lymphocytes, are located in the unique microenvironment of germinal centers in close proximity
to antigen-retaining follicular dendritic cells (FDC). Observations that TBM endocytose FDC-
iccosomal (immune-complex coated bodies) antigen suggested that TBM might present this
antigen and help regulate the germinal center reaction. To test for antigen presentation, the
ovalbumin (OVA)-specific TI hybridoma, 3DO-54.8, which produces IL-2 on receiving
effective presentation of OVA, were used as responders to OVA-bearing TBM. Results showed
that OVA-bearing TBM failed to induce IL-2 production. Furthermore, addition of TBM to IL-
2-inducing positive controls (B cells) not only failed to augment IL-2 production, but rather
TBM significantly (55-90%) reduced B-cell induction of IL-2. We found that TBM were rich in
prostaglandin by comparison with other nongerminal center lymph node macrophages and that
addition of indomethacin to the cultures reversed the inhibitory effect of TBM. Depletion of
TBM from enriched preparations, prior to addition to positive control cultures, also abrogated the
inhibitory effect on IL-2 production. These data support the concept that TBM, within the unique
microenvironment of germinal centers, may be specialized to downregulate the germinal center
reaction.
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INTRODUCTION
Macrophages represent a heterogenous population,
and macrophage functions are influenced by the
microenvironment in which they reside. By definition,
tingible body macrophages (TBM), a subset of the
mononuclear phagocytes, are unique, large phago-
cytic cells that reside in germinal centers of secondary
*Corresponding author.
lymphoid tissues (Flemming, 1885). TBM contain
many phagocytized, apoptotic cells (referred to as
tingible bodies) (Flemming, 1885) in various states of
degradation (Swartzendruber and Congdon, 1963).
Unique to this subset of macrophages is the germinal
center microenvironment, characterized functionally
by long-term antigen retention on follicular dendritic
cells, antigen presentation by B cells to T-helper cells,
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TABLE Antigen Presentation of In Vivo Obtained and Exogenous Antigen by TBM-Enriched Cells
Experiment no. TBM TBM + OVA IL-2 control
1,240 165 25,000 _+ 1,800 322,000 _+ 5,900
2 190 _+ 50 250 10 181,000 1,400
3 300 _+ 90 950 120 364,000 _+ 10,240
4 770 100 4,340 _+ 40 60,000 _+ 3,600
al.0 105 TBM-enriched cells were cultured for 24 hr with 3 10 3DO-54.8 Tl cells. Results shown were always greater than control
cultures of 3DO cells or TBM alone.
bl.0 )< 10 TBM-enriched cells and 50/xg OVA were cultured for 24 hr with 3 10 3DO-54.8 Tni cells.
c3 10 CTL cells were cultured with either 50/xl IL-2 containing Con A supernatant or 50/xM human rIL-2.
aData represent 3H-thymidine incorporation by 3 104 IL-2-dependent CTLL cells and are expressed as mean cpm +_ standard errors of
triplicate cultures.
a high rate of somatic mutations, affinity maturation,
induction of antibody-forming cells and memory B-
cell development (Coico et al., 1983; Szakal et al.,
1989; Tew et al., 1990). Although the scavenging
function of TBM in germinal centers is obvious, it has
also been suggested that TBM may be important in
initiating the germinal center reaction (Kamperdijk et
al., 1978, 1982).
Regarding the germinal center reaction, it has been
shown that germinal center B cells are extremely
effective antigen-presenting cells. Three to eight days
after a booster immunization, germinal center B cells
obtain antigen from FDCs in the form of immune
complex coated bodibs (iccosomes) and are capable
of processing and presenting the iccosomal antigen to
T cells in an MHC-restricted manner (Kosco et al.,
1988; Szakal et al., 1988). Typically, macrophages
phagocytose antigens, process them, express them on
class II molecules, and present the processed antigen
to T-helper cells. Observations that TBM, like
germinal center B cells, also endocytosed iccosomes
(Szakal et al., 1988) and that many TBM are class II
positive (Smith et al., 1988), suggest that TBM might
also be able to present the FDC-derived antigen to T
cells (Smith et al., 1988).
The objectives of the present study was to deter-
mine if TBM can indeed present antigen and if
antigen presentation by TBM may be implicated in
the regulation of the germinal center reaction. The
results showed that TBM-enriched preparations were
not good antigen presenters but were highly effective
inhibitors of T-cell lymphokine secretion induced by
B cells. Selective depletion of TBM from the enriched
preparations and/or addition of the prostaglandin
synthesis inhibitor indomethacin to the cultures
restored lymphokine activity. Histochemical observa-
tions confirmed that TBM are a rich source of
prostaglandins. Thus, these data are consistent with
the concept that the microenvironment of germinal
centers favors an inhibitory role for TBM in the
regulation of the germinal center reaction via a
prostaglandin-mediated mechanism.
RESULTS
Antigen Presentation
Germinal center B cells obtain antigen from FDC for
processing and presentation to T cells during a period
between 3 and 8 days after booster immunization.
Typically, numerous germinal center B cells (20%)
were present in the TBM preparation and both TBM
and germinal center B cells take up iccosomes (Kosco
et al., 1988; Szakal et al., 1988). Therefore, we
reasoned that the addition of TBM-enriched cells
from an OVA-immune animal to the OVA-specific T-
cell hybridoma 3DO-54.8 should result in antigen
presentation and IL-2 production. As shown in Table
I, there was no evidence of presentation of in vivo
obtained antigen by the TBM preparation. When
antigen was added in vitro (TBM + OVA), to be
certain that antigen was not limiting, a significant (p <
0.01) but very modest level of IL-2 production was
detected in two experiments (Table I, Experiments 1
and 4). In both cases, the production of IL-2 was less
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TABLE II Effect of TBM-Enriched Cell Preparations on Antigen Presentation by B Cells
Experiment no. B cells + OVA B cells + OVA + TBM % Suppression IL-2 control
165,000 +_ 9,300 16,000 +_ 600 90.0 322,000
2 8,800 330 2,700 300 70.0 22,000
3 132,000 8,300 13,550 +_ 1,600 90.0 102,000
4 96,400 5,700 42,700 6,350 55.0 60,000
3DO-54.8 Tr cells (3 104) were cultured for 24 hr with:
aGerminal center B cells (106) or TA3 B-cell hybridoma’/(104) and 50 #g OVA (positive control cultures).
bFootnote a and 105 TBM-enriched cells.
c3 10 CTLL cells were cultured with either 50/xl IL-2 containing Con A supernatant or 50/zM human rIL-2.
dData represent 3H-thymidine incorporation by 3 10 IL-2-dependent CTLL cells and are expressed as mean cpm _+ standard errors of
triplicate cultures. In Experiments to 3, the values for 3DO cells or TBM cultured alone were always less than 500. In Experiment 4, the
values for cultures of 3DO alone and TBM alone were 1532 67 and 1087 53, respectively.
TABLE III Indomethacin Relieves Suppression Associated with TBM-Enriched Cells
Exp. no. B cells + OVA B cells + OVA + TBM % of positive B cells + OVA TBM + INDO % of positive
(positive control) control cultures control cultures
7,100 700 2,600 750 37 9,076 _+ 650 129
2 8,800 +_ 300 2,700 +_ 320 30 7,260 _+ 200 82
3 132,000 _+ 8,000 13,500 _+ 1,600 10 81,000 _+ 1,000 61
4 96,400 +_ 5,700 42,700 6,350 40 66,300 10,300 69
3DO-54.8 T1 cells (3 104) were cultured for 24 hr with:
aGerminal center B cells (106) or TA3 B-cell hybridoma’/(104) and 50/zg OVA.
bFootnote a and 105 TBM-enriched cells. Values for 3DO cells and TBM alone were always less than 500 cpm.
CFootnote b and 100/zM indomethacin.
dData represent 3H-thymidine incorporation by 3 10 IL-2-dependent CTLL cells and are expressed as mean cpm _+ standard errors of
triplicate cultures.
than 10% of the response attained in the control when
a near optimal level of IL-2 was added.
To determine if TBM might suppress antigen
presentation, TBM-enriched cells were cocultured
with 3DO cells and B cells in the presence of OVA.
The results from four experiments are shown in Table
II. A 55-90% suppression of the IL-2 response was
observed when TBM-enriched populations were
added.
Effect of Indomethacin on TBM Suppression of
Antigen Presentation
Macrophages are a major source of prostaglandins
and generally the larger most phagocytically active
macrophages are the most prolific prostaglandin
producers (Lee and Berry, 1977; Lee and Wong,
1982; Guidos et al., 1987). The striking phagocytic
activity of TBM and their large size prompted us to
reason that TBM might suppress through a prosta-
glandin-dependent mechanism. To begin testing this,
the prostaglandin synthesis inhibitor indomethacin
was added to cultures containing TBM-enriched cells,
B cells, and 3DO cells in the presence of OVA. As
shown in Table III, the addition of 100 #M indom-
ethacin relieved most of the suppression of IL-2
production in TBM-containing cultures. Controls
showed that indomethacin did not inherently augment
the IL-2 response in positive control cultures. Further-
more, indomethacin did not inherently increase the
proliferation of CTLL over background levels (data
not shown).
TBM and Prostaglandins
PGE2 is made by a membrane-bound prostaglandin
synthetase. We reasoned that antibody specific for
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Depending on the stage of maturation, state of
activation, and source, macrophages have been
reported to either enhance or suppress immune
responses (Stenson and Parker, 1980). Classically,
macrophages are believed to be important accessory
cells for antigen presentation (Rosenthal and Shevach,
1973a, 1973b; Unanue, 1981). A requirement for
macrophages to function as accessory cells is the
expression of MHC products. In contrast, in many
cases, it has been shown that macrophages do not
function as accessory cells but instead suppress
immune reactions (Parkhouse and Dutton, 1966). In a
series of publications by Lee and colleagues, it was
suggested that the functional heterogeneity expressed
by macrophages in the modulation of immune
responses can be differentiated according to macro-
phage size as measured by velocity sedimentation
rates (Lee and Berry, 1977; Lee and Wong, 1982;
Guidos et al., 1987). Antigen-presenting activity was
found to be characteristic of small macrophages,
whereas large macrophages tended to be immuno-
suppressive. Furthermore, large macrophages that
were induced to express class II molecules also
exhibited suppressive effects on immune responses.
Thus, the large size of TBM, even though they
express class II (Smith et al., 1988) is compatible with
the hypothesis that TBM may have a suppressive
function to downregulate or limit the germinal center
reaction.
Prostaglandins appear to be responsible for much
of the immunosuppression mediated by macrophages.
The suppressive effects of prostaglandins on immune
responses are diverse and have been reviewed (Sten-
son and Parker, 1980; Goodwin and Ceuppens, 1983).
The binding of immune complexes by macrophages
stimulates phagocytosis, which in turn stimulates
prostaglandin synthesis with the major product being
PGE2 with smaller amounts of PGF1 (Bonney et al.,
1979). This immune-complex stimulation may help
explain the high level of prostaglandin in TBM since
they may encounter immune complexes directly on
the processes of FDC and in the form of iccosomes
(Szakal et al., 1988). The data in this study show that
indomethacin, an inhibitor of prostaglandin synthesis,
abrogates the suppressive effect of the TBM prepara-
tion on B-cell antigen presentation. Controls indicated
that indomethacin did not inherently augment the IL-2
response in the assay system (data not shown). A
known suppressive effect of prostaglandins on
immune responses is the inhibition of lymphokine
synthesis by TH cells. Whereas most of the lympho-
cytes in germinal centers are B cells, a small number
of T cells are present and most of these T cells are of
the helper phenotype (Rouse et al., 1982a, 1982b).
Interestingly, a close association between TBM and
germinal center T cells has been observed (Nieu-
wenhuis and Opstelten, 1984, and unpublished).
Germinal centers are sites of memory B-cell
production (Coico et al., 1983) and production of
memory B cells involves somatic mutation and
maintenance of B cells that express high-affinity
receptors for the stimulating antigen (Wysocki et al.,
1986). It has been suggested that B cells with low-
affinity antigen receptors cannot compete for antigen
persisting on FDC and are clonally deleted (Wysocki
et al., 1986). The tingible bodies in TBM may
represent phagocytized low-affinity B cells that have
been condemned to undergo apoptosis (Manser et al.,
1987; Schad and Phipps, 1988). Consistent with this
hypothesis, Odartchenko et al. (1966) and Fliedner
(1967) have reported that the majority of the tingible
bodies located in TBM represent cells that have died
either during late G2 phase or just prior to a mitotic
event.
It has also been suggested that TBM play an active
role in initiating the germinal center reaction (Kam-
perdijk et al., 1978, 1982). This suggestion was based
on the observations that TBM initially appeared at the
onset of germinal center development and that peak
numbers of TBM were seen at peak germinal center
development. However, in recent studies, it has been
shown that TBM are not absolutely essential for
germinal center development. Germinal centers can
develop in old mice in the absence of TBM (Smith et
al., 1990). The data shown in this report are consistent
with a regulatory role for TBM and it appears that
TBM are more likely to down regulate than to
stimulate the germinal center reaction.
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MATERIALS AND METHODS
Animals
Ten- to sixteen-week-old female Balb/C (H-2d) mice
were purchased from Charles River Laboratories
(Wilmington, MA). The animals were housed under
pathogen-free conditions in standard cages equipped
with filter tops and allowed food and water ad
libitum.
Cell Lines and mAb
The TH1 cell hybridoma 3DO-54.8 was a gift from J.
Kappler and P. Marrack (National Jewish Hospital,
Denver). Cultures of 3DO-54.8 cells (3DO) produce
IL-2 when stimulated by the antigen ovalbumin
(OVA) recognized in the context of the MHC
molecule I-Ad. The IL-2-dependent cytotoxic lym-
phocyte line CTLL used to assay IL-2 was provided
by P. Allen and E. Unanue (Washington University,
St. Louis). The B-cell hybridoma TA3 (I-ATM) was a
generous gift from Laurie Glimscher. Supernatants
from the hybridoma M3/38 (obtained from Hybritech,
San Diego) was used as the source of anti-Mac-2
antibody. Anti-Thy-1 antibody was obtained from
Pharmingen (San Diego). Recombinant human IL-2
was obtained from Southern Biotech.
Immunizations
Active immunization.
Germinal center B cells were obtained from ovalbu-
min (OVA; #A5503, Sigma Chemical, St. Louis)-
immune mice. Mice were injected with 0.5 mg of
OVA emulsified with complete Freunds adjuvant
(CFA, Difco Laboratories, Detroit) behind the neck
followed by a second 0.5-mg injection of OVA in
CFA 14 days later. Seven days prior to germinal
center B-cell isolation, mice received challenge
injections of 0.5/g OVA in all footpads. Anti-OVA
sera was prepared in rabbits immunized subcuta-
neously with 1.0 mg OVA emulsified in CFA
followed by a booster immunization without CFA.
Rabbits were bled via ear veins 7 days after booster
immunization.
Passive immunization.
Phagocytosis of Freunds adjuvant by TBM and other
macrophages can affect their densities and can cause
erroneous isolation and the identification of non-TBM
macrophages as TBM. Therefore, to obtain a popula-
tion of TBM not contaminated by Freunds-adjuvant-
containing macrophages, mice were passively
immunized by intraperitoneal injections of 0.5 ml of
rabbit anti-OVA. Eighteen to twenty-four hours later,
challenge injections of 8-10 /g of OVA diluted in
0.9% phosphate-buffered saline (PBS), pH 7.4, were
injected into all four footpads. By using this immun-
ization protocol, germinal center development and
TBM were first evident 3 days after the antigenic
challenge. Optimal numbers of TBM were present
8-10 days after challenge (Smith et al., 1990; Tew et
al., 1990).
Isolation and Enrichment of TBM and B Cells
Techniques for obtaining enriched populations of
TBM (Smith et al., 1988) and germinal center B cells
(Kosco et al., 1988) were previously described in
detail. Briefly, 8 to 10 days after antigen challenge of
OVA immune mice, lymph nodes were collected,
enzymatically dissociated, and enriched on a discon-
tinuous Percoll (Pharmacia, Piscataway, NJ) gradient
(densities 1.042 and 1.064). Cells at the 1.064
interface were collected, washed, and incubated in
tissue-culture dishes (Costar #3100, Cambridge, MA)
at 37C for 45 rain to remove strongly adherent cells,
which were primarily typical macrophages. Weakly
adherent cells, including TBM, were then flushed off
the culture dishes using a Pasteur pipette and counted.
This population consisted of 7-10% TBM, 50-60% B
cells (including about 20% PNAhi GC B cells) and
30-35% T cells.
Enriched populations of germinal center B cells
were obtained as previously described (Kosco et al.,
1988). Briefly, lymph nodes from actively immunized
mice were collected at 3 and 5 days after challenge
with OVA, enzymatically dissociated, and enriched
on a continuous Percoll gradient. Further enrichment
was achieved by panning for germinal center B cells
on peanut agglutinin (PNA; Sigma)-coated tissue-
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culture dishes (Costar #3100). Unbound cells were
removed by gentle swirling and PNA-positive germi-
nal center B cells were then eluted from the dishes by
adding 0.2 M d-galactose (Sigma) for 1 hr before
vigorous flushing with a pipette. By using this
technique, 70-80% enriched populations of highly
PNA germinal center B cells were commonly
attained.
Depletion of TBM Using Dynabeads
It is known that TBM are the only Mac-2-bearing
cells in lymph nodes (Flotte et al., 1983; Smith et al.,
1990), and, in addition, TBM also express Thy-1
(Smith et al., 1988). Consequently, TBM can be
selectively removed from TBM-enriched cell popula-
tions using anti-Mac-2 and anti-Thy-1 on immuno-
magnetic beads (Dynal, Great Neck, NY). The beads
were purchased precoated with Fc-specific sheep anti-
rat IgG. The beads were washed five times, incubated
with a cocktail of anti-Mac-2 (1:4 dilution) and mouse
anti-rat Thy-1 (1:20) for 1 hr at 4C with intermittent
agitation, and gently washed three times with HBSS.
The beads were then incubated with the Mac-2/Thy-
1-treated TBM-enricheff preparation at a bead-to-cell
ratio of 40:1 for 30 min on ice with gentle intermittent
agitation. Following incubation, the Dynabead roset-
ted TBM were removed using the Dynal magnetic
chamber. The remaining cells were collected with a
Pasteur pipette, washed, and adjusted to 2 105 cells/
50/zl in complete media. This preparation was used
as the TBM-depleted population.
IL-2 Assay for Antigen Presentation
Antigen presentation was assessed using an assay
system similar to the one originally described by
Shimonkevitz et al. (1983). In this system, the OVA-
specific Try-cell hybridoma 3DO-54.8 (3DO) will
produce the lymphokine IL-2 when cocultured with
OVA and a source of antigen-presenting cells. The
production of IL-2 can then be quantitated by
transferring aliquots of media from the cocultured
cells to the IL-2-dependent T-cell line CTLL. The
presence of IL-2 in the media stimulates the prolifera-
tion of CTLL cells, which can be measured by 3H-
thymidine incorporation. Ultimately, then, the pro-
liferation of CTLL serves as an index for antigen
presentation. From 5 104 to 106 antigen-
presenting cells (germinal center B cells or TA3 cells)
were cocultured with 3.0 104 3DO cells in 96-well
flat-bottom plates (Falcon #3596) at 37C, in 5% CO2
atmosphere for 24 hr in the presence of 50 /zg of
OVA. RPMI 1640 (GIBCO, Grand Island, NY)
supplemented with 10% pyrogen-free fetal calf
serum, 100 /zg/ml gentamicin (GIBCO), 0.2 mM
glutamine (GIBCO), and 10 mM Hepes buffer
(GIBCO) was used as the culture media. Positive
controls for antigen presentation were either (1)
cocultures of 5 105 to 1.0 106 germinal center B
cells with 5.0 104 3DO cells in the presence of 50
/zg of OVA or (2) 5.0 104 TA3 cells with 3.0 104
3DO cells in the presence of 50/zg OVA.
To assess the production of IL-2 by 3DO cells,
150-/zl aliquots of coculture media were transferred to
3 104 CTLL cells in 96-well U-bottom plates
(Costar #3799) and cultured for 24 hr at 37C, at 5%
CO2 atmosphere. At 16-20 hr, each well was pulsed
with 1.0 /xCi 3H-thymidine (New England Nuclear,
Boston) and harvested (PHD Harvester, Cambridge
Technical) at 24 hr onto glass filter strips (Costar,
#240-1). Proliferation of CTLL cells induced by IL-2
in the coculture media was then measured as thymi-
dine incorporation using a Packard 2200CA scintilla-
tion counter. All culturing were performed in tripli-
cate and the data were expressed as the mean
3H-thymidine uptake. Cultures of CTLL cells alone
and supernatant from 3DO cells alone in the presence
or absence of OVA were used as controls and were
consistently negative (mean cpm _+ standard error
461
_
76). As a control for T-cell contamination in the
germinal center B-cell preparation, germinal center B
cells were cultured alone in the presence of antigen.
The germinal center B-cell preparation appeared to
contain some T cells, as indicated by slight but
inconsequential IL-2 production when cultured in the
presence of antigen.
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Influence of TBM on Antigen Presentation by
Germinal Center B Cells
To determine if TBM have an affect on the capacity
of B cells to present antigen, 1-2 105 TBM-
enriched cells (containing 14,000-16,000 TBM) were
cocultured with B cells (either 5.0 105 to 1.0 106
germinal center B cells or 5.0 104 TA3 cells) and
3.0 X 104 3DO cells in the presence of 50/xg OVA.
As in the antigen-presenting assay, in some cultures,
TBM were removed from the enriched preparations
using Mac-2-coated Dynabeads prior to culturing. In
some experiments, 50 /xl of 100 /xM indomethacin
(Sigma, St. Louis), a prostaglandin inhibitor, was
added. Prostaglandins are known to inhibit IL-2
synthesis. As a control, to ensure that indomethacin
did not inherently affect the assay, indomethacin was
also added to cocultures of germinal center B cells,
antigen, and 3DO cells in the absence of TBM-
enriched cells.
lmmunocytochemistry
Reactivity for prostaglandins was detected on
enriched preparations of TBM using indirect perox-
idase immunocytochemistry. Paraformaldehyde/glu-
taraldehyde-fixe cytobucket (IEC) slide preparations
of TBM-enriched populations were incubated for 30
min at 4C with goat anti-human PGE2 (1:30) (ICN,
Irvine, CA) as the primary antibody. The slides were
washed 3 5 min with 0.1 M cacodylate buffer
followed by incubation with a peroxidase-conjugated
rabbit anti-goat IgG (1:100) as the secondary anti-
body. Specific peroxidase activity was localized,
using DAB as chromogen, and endogenous perox-
3DO
-i-
B cells
-l-
OVA
TBM
enriched lepleted
cell prep.[ ell prep.
Indo-
methacin
/ /
+ + +
+ /
+ + +
Effect of TBM Depletion on B cell
Antigen Presentation
CPM X 1000
FIGURE 2 Effect of depletion of TBM from TBM-enriched populations on lymphokine secretion. TBM-enriched cells (1 105), depleted
of TBM by MAC-2/THY-l-coated Dynabeads (-TBM), or nondepleted (+TBM) were cocultured with positive antigen-presenting cultures
(3DOs + B cells + OVA) in the presence or absence of 100/xM of indomethacin. Data represent proliferation of CTLL cells in response
to IL-2 produced in coculture supernatants and are expressed as mean cpm +_. standard error of triplicate cultures.
TBM’S AND THE GERMINAL CENTER REACTION 293
idase activity was inhibited according to the method
of Herzog and Miller (1972).
Depletion of TBM Relieves Suppression of IL-2
Activity
If the TBM were responsible for depressing the IL-2
production, depletion of the TBM from the enriched
preparation prior to addition to the control cultures
should alleviate the suppression. Results from a
representative experiment using TBM-depleted cells
are shown in Fig. 2. Addition of the TBM-enriched
population to positive controls resulted in dramatic
depression of IL-2 production--about 10% of posi-
tive control cultures. Addition of indomethacin to
cultures containing TBM-enriched cells resulted in a
restoration of most of the IL-2 activity. Furthermore,
depletion of TBM from TBM-enriched populations
restored IL-2 production to a level insignificantly less
than that of the positive controls.
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